Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants
- PMID: 38472593
- DOI: 10.1007/s10549-024-07261-6
Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants
Abstract
Objective: To determine the risk of breast cancer due to lobular carcinoma in situ (LCIS).
Methods: This retrospective IRB-approved study identified cases of LCIS after percutaneous breast biopsy from 7/2005 to 7/2022. Excluded were cases with less than 2 years of imaging surveillance or a concurrent ipsilateral breast cancer diagnosis within 6 months of the LCIS diagnosis. Final outcomes of cancer versus no cancer were determined by pathology at surgical excision or the absence of cancer on imaging surveillance.
Results: A total of 116 LCIS lesions were identified. The primary imaging findings targeted for percutaneous biopsy included calcifications (50.0%, 58/116), MR enhancing lesions (25.0%, 29/116), noncalcified mammographic architectural distortions (10.3%, 12/116), or masses (14.7%, 17/116). Surgical excision was performed in 49.1% (57/116) and imaging surveillance was performed in 50.9% (59/116) of LCIS cases. There were 22 cancers of which 11 cancers were discovered at immediate excision [19.3% (11/57) immediate upgrade] and 11 cancers developed later while on imaging surveillance [18.6% (11/59) delayed risk for cancer]. Among all 22 cancers, 63.6% (14/22) occurred at the site of LCIS (11 at immediate excision and 3 at surveillance) and 36.4% (8/22) occurred at a location away from the site of LCIS (6 in a different quadrant and 2 in the contralateral breast).
Conclusion: LCIS has both an immediate risk (19.3%) and a delayed risk (18.6%) for cancer with 90.9% occurring in the ipsilateral breast (63.6% at and 27.3% away from the site of LCIS) and 9.1% occurring in the contralateral breast.
Keywords: Cancer; Florid; Lobular carcinoma in situ; Pleomorphic; Variant.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- American Society of Breast Surgeons website. Consensus guideline on concordance assessment of image-guided breast biopsies and management of borderline or high-risk lesions. www.breastsurgeons.org/docs/ statements/Consensus-Guideline-on-Concordance-Assessment-of-ImageGuided-Breast-Biopsies.pdf. Accessed April 4, 2023.
-
- Lewin AA, Mercado CL (2020) Atypical ductal hyperplasia and lobular neoplasia: update and easing of guidelines. AJR Am J Roentgenol 214(2):265–275. https://doi.org/10.2214/AJR.19.21991 - DOI - PubMed
-
- Falomo E, Adejumo C, Carson KA, Harvey S, Mullen L, Myers K (2019) Variability in the management recommendations given for high-risk breast lesions detected on image-guided core needle biopsy at U.S. academic institutions. Curr Probl Diagn Radiol 48(5):462–466. https://doi.org/10.1067/j.cpradiol.2018.06.004 - DOI - PubMed
-
- Krishnamurthy S, Bevers T, Kuerer HM, Smith B, Yang WT (2017) Paradigm shifts in breast care delivery: impact of imaging in a multidisciplinary environment. AJR Am J Roentgenol 208(2):248–255. https://doi.org/10.2214/AJR.16.17130 - DOI - PubMed
-
- Sokolova A, Lakhani SR (2021) Lobular carcinoma in situ: diagnostic criteria and molecular correlates. Mod Pathol 34(Suppl 1):8–14. https://doi.org/10.1038/s41379-020-00689-3 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical